Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_assertion type Assertion NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_head.
- NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_assertion description "[A higher rate of NY-ESO-1 expression was noted in breast cancer with high histological grade and negative hormone receptor status, suggesting NY-ESO-1 as a potential tumor antigen for immunotherapy in patients with breast cancer and poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_provenance.
- NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_assertion evidence source_evidence_literature NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_provenance.
- NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_assertion SIO_000772 15026363 NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_provenance.
- NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_assertion wasDerivedFrom befree-20140225 NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_provenance.
- NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_assertion wasGeneratedBy ECO_0000203 NP260000.RAa_jRAPbv1dIuX_YVQ_20TdVMf_kmbCMT6v_s3hhL6_M130_provenance.